Biotechnology
Rentschler Biopharma Appoints Detra Glinatsis As Head Of Business Development U.S.
Share
LAUPHEIM, Germany and MILFORD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Detra Glinatsis has rejoined the company as Head of Business Development U.S. In this newly created role, Ms. Glinatsis will lead all business development activities related to the U.S. market. She reports to Dr. Patrick Meyer, Global Head of Business Development, and is based at the company’s site in Milford, MA.
Dr. Patrick Meyer, Global Head of Business Development at Rentschler Biopharma, commented: “I am excited to have Detra rejoin Rentschler Biopharma to serve in this important role. Her career is a true testament to her expertise, client‑centric mindset, and ability to build long‑lasting, meaningful partnerships. The United States is a cornerstone of our commercial strategy, and our presence in Milford, MA enables us to bring Rentschler Biopharma’s innovative thinking and development strength directly to the doorstep of our clients. In the past two years, we have successfully transferred one post‑PPQ* commercial program to the site, are advancing three additional programs toward PPQ, and initiated manufacturing for six new products in 2025 – clear proof of the momentum Detra will now help to accelerate. Expanding our U.S. business is critical to the next growth stage of our corporate strategy, and Detra, with her commitment to excellence and exceeding client expectations, is the ideal person to lead our U.S. business development activities.”
Detra Glinatsis brings over twenty years of sales and business development experience in the pharmaceutical, biotech and contract manufacturing industries. She rejoins Rentschler Biopharma from Northway Biotech, where she was Vice President, Business Development. She previously held roles of increasing responsibility at AGC Biologics, Sartorius, Gallus BioPharmaceuticals, and Avecia Biologics, as well as Rentschler Biopharma, where, earlier in her career, she was Senior Director, Business Development. Ms. Glinatsis holds a B.S. in biology from the University of Akron.
Detra Glinatsis, Head of Business Development U.S., said: “I am thrilled to come back to Rentschler Biopharma as the company continues to grow its U.S. business. Together with the team, I look forward to building on the success that the company has achieved with the Milford site expansion and continuing to enhance the Rentschler Biopharma brand in the U.S. The company has a long-standing reputation for top quality and reliability, and I am excited to be working with such a talented team with a coveted track record.”
_________
* PPQ = Process Performance Qualification
About Rentschler Biopharma SE
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. In 2024, the company joined the United Nations Global Compact, emphasizing Rentschler Biopharma's focus on sustainability. For further information about the company, please visit www.rentschler-biopharma.com. Follow Rentschler Biopharma on LinkedIn.
Contact:
Rentschler Biopharma SE
Dr. Latika Bhonsle-Deeng
Global Head of Communications
Phone: +49-7392-701-467
communications@rentschler-biopharma.com
Media inquiries:
| MC Services AG Eva Bauer Phone: +49-89-210228-0 rentschler@mc-services.eu | U.S. Laurie Doyle Phone: +1-339-832-0752 |
Frequently Asked Questions
Who is Detra Glinatsis and what is her new role?
Detra Glinatsis has rejoined Rentschler Biopharma SE as Head of Business Development U.S., leading all business development activities for the U.S. market. She brings over twenty years of experience in the pharmaceutical, biotech, and contract manufacturing industries.
What services does Rentschler Biopharma SE provide?
Rentschler Biopharma SE is a leading contract development and manufacturing organization (CDMO) specializing in process development and manufacturing of biopharmaceuticals, along with related consulting, project management, and regulatory support.
Why is the U.S. market important for Rentschler Biopharma?
The United States is a cornerstone of Rentschler Biopharma's commercial strategy. The company is expanding its U.S. business, leveraging its Milford, MA site to bring innovative development strength directly to clients and accelerate growth.
First published on Fri, Jan 23, 2026
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
Loyaltylion Launches AI Campaigns To Help Shopify Brands Drive More Loyalty Revenue
Overworld Unveils Real-Time Diffusion World Model For Playable, AI-Native Worlds
Intuitive.Ai Partners With Matilda Cloud To Accelerate Secure, Compliant AI And Cloud Modernization For Life Sciences
AI-First Hits Amazon Best Sellers List: The Executive Blueprint For Transformation
Activengage To Unveil AI Suite Of Products At NADA Show 2026
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion